Status:
COMPLETED
Parental Experience in the Single Ventricle Interstage Utilizing a mHealth Innovation: A Comparative Case Study
Lead Sponsor:
Children's Mercy Hospital Kansas City
Collaborating Sponsors:
American Nurse Credentialing Center
Conditions:
mHealth
Adherence, Patient
Eligibility:
All Genders
Brief Summary
The purpose of this study is to provide a rich description of the parental perspectives of utilizing a mHealth application for data transfer during the single ventricle interstage monitoring period. A...
Detailed Description
Background Nearly 2,000 infants with single ventricle cardiac disease are born each year in the United States, and have near certain mortality without surgical intervention. The heart with this congen...
Eligibility Criteria
Inclusion
- Adult over 18 years of age parent(s) of children with single ventricle cardiac disease
- Parent(s) of children were discharge home in the interstage period from December 2013 to May 2017 that have completed the interstage period with Stage II Glenn cardiac surgery as of June 8th, 2017.
- Parents(s) of children who were followed in the CHAMP clinic at Children's Mercy.
- Parent(s) of CHAMP children who had the CHAMP mHealth application (CHAMP App) available for transfer of home monitoring data during the interstage
Exclusion
- Non-English speaking parent(s)
- Parent(s) of children who were not discharged interstage
Key Trial Info
Start Date :
September 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03231020
Start Date
September 13 2019
End Date
May 30 2020
Last Update
July 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Kansas City
Kansas City, Missouri, United States, 64108